The findings suggested that NSCLC tissues showed much lower levels of both PRKACB mRNA and protein than the corresponding normal tissues and in transfected cancer cell lines, PRKACB upregulation reduced the number of proliferative, clonogenic, and invasive cells, while apoptosis rates was increased[42]. The gene discussed is PRKACB; the disease is non-small cell lung carcinoma.